Avraham Hochberg
Keine laufenden Positionen mehr
Karriereverlauf von Avraham Hochberg
Ehemalige bekannte Positionen von Avraham Hochberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | 14.10.2010 | 22.01.2017 |
| Vorsitzender | 01.01.2004 | 12.03.2010 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 22.01.2017 | |
| Gründer | 12.03.2010 | 22.01.2017 | |
| ANCHIANO THERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 01.01.2004 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.10.2016 | |
| Gründer | 01.01.2004 | 01.10.2016 |
Ausbildung von Avraham Hochberg
| The Hebrew University of Jerusalem | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Israel | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
- Börse
- Insiders
- Avraham Hochberg
- Erfahrung
